Dr Neil Hudson

Synthetic Chemicals

As shadow DEFRA Minister, I congratulate and thank the Chair of the Committee and his cross-party Environmental Audit Committee for this excellent and timely report. As he has said, PFAS—these forever chemicals—are hugely damaging to the environment and pose significant risks to human health, animals and wildlife. The previous Government started work with the Environment Agency and the Health and Safety Executive to look at monitoring and risk, and as the Chair said, the current Government have

Peter Mandelson: Government Appointment

We have heard a lot from Labour Members today about process, but will the Chief Secretary to the Prime Minister please tell my constituents, the House and the country why on earth the Prime Minister appointed Peter Mandelson to be ambassador to the United States?

Ehlers-Danlos Syndrome and Craniocervical Instability

I thank the hon. Member for Cannock Chase (Josh Newbury) for securing this important debate. I apologise, Ms Furniss, that I was not in the Chamber for the beginning of it; my shadow ministerial role in relation to the Department for Environment, Food and Rural Affairs meant that I had to be in the main Chamber at the start of this debate. Will the Minister join me in paying tribute to patients with Ehlers-Danlos syndrome and craniocervical instability—including my constituent in Epping Forest,

Coastal Erosion

I congratulate the hon. Member on her powerful contribution, and also congratulate the cross-party EFRA Committee on its thoughtful and thought-provoking report. Coastal communities are at the frontline of adverse weather events and the negative effects of climate change, and the report highlighted the human impact on those communities, and specifically their mental health. It echoed a lot of the findings of the previous EFRA Committee in the last Parliament—we produced a report on rural mental

EU-UK Sanitary and Phytosanitary Agreement: Negotiations

Stakeholders have expressed alarm about the fact that the Government’s guidance for businesses on the UK-EU SPS agreement, published last week, has legislation in scope on the use of hormones, including bovine somatotrophin, in livestock. The use of growth-promoting hormones for livestock and of bovine somatotrophin are rightly banned in the UK and EU because of serious animal welfare issues and public health concerns, and bovine somatotrophin is linked to a 25% increase in mastitis in cows. For